Methylphenidate
Back to searchMolecule Structure
Scientific Name
Methylphenidate
Description of the Drug
Methylphenidate is a stimulant used in the management of Attention Deficit Hyperactivity Disorder (ADHD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00422
http://www.drugbank.ca/drugs/DB00422
Brand Name(s)
Concerta, Cotempla xr-odt, Daytrana
Company Owner(s)
Alkem Laboratories Ltd, Eywa Pharma Inc, Abhai Inc, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Osmotica Pharmaceutical Us Llc, Rhodes Pharmaceuticals Lp, Mountain Llc, Granules Pharmaceuticals Inc, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL238 |
| Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL37178 | |||||
| PharmGKB | PA10054 | PA450464 | ||||
| Human Metabolome Database | HMDB0014566 | |||||
| DrugBank | DB00422 | |||||
| PubChem: Thomson Pharma | 14798219 | |||||
| PubChem | 4158 | |||||
| Nikkaji | J5.133K | |||||
| BindingDB | 50062912 | |||||
| EPA CompTox Dashboard | DTXSID5023299 | |||||
| DrugCentral | 1767 | |||||
| Brenda | 75630 | 161165 | 148403 | |||
| Guide to Pharmacology | 7236 | |||||
| rxnorm | METHYLPHENIDATE HYDROCHLORIDE | CONCERTA | METHYLIN | DAYTRANA | RITALIN | METHYLPHENIDATE |
| KEGG Ligand | C07196 | |||||
| ChEBI | 84276 |
